Omada Health, Inc. earnings releases OMDA

Omada Health, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $91.3 million (+34.2% year over year) and diluted EPS of $0.10. It usually reports 12–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 5, 2026
36 days after quarter end
From press release
Q3 FY2026
ended Sep 30, 2026
91
+34.2%
—
0.10
+266.7%
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
88
+43.1%
5
+199.7%
0.08
+133.3%
May 7, 2026
37 days after quarter end
Q1 FY2026
ended Mar 31, 2026
78
-3
-0.05
Jan 12, 2026
12 days after quarter end
Q4 FY2025
ended Dec 31, 2025
76
5
0.09
Nov 6, 2025
37 days after quarter end
Q3 FY2025
ended Sep 30, 2025
68
-3
-0.06
Aug 7, 2025
38 days after quarter end
Q2 FY2025
ended Jun 30, 2025
61
-5
-0.24

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
OMDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
, Emerging growth company
SEC CIK
1611115

Other Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.